☆ 4.1 Article

Chemical Complementarity of Tumor Resident, Adaptive Immune Receptor CDR3s and Previously Defined Hepatitis C Virus Epitopes Correlates with Improved Outcomes in Hepatocellular Carcinoma

VIRAL IMMUNOLOGY (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Biochemistry & Molecular Biology

Chemical complementarity between immune receptor CDR3s and candidate cancer antigens correlating with reduced survival: evidence for outcome mitigation with corticosteroid treatments

Anishaa R. Patel et al.

Summary: Evaluation of adaptive immune receptor (IR) recombination sequences has shown correlations with diseases, especially cancer, focusing on the complementarity determining region-3 (CDR3) amino acid (AA) sequences. High chemical complementarity scores (CS) between IR CDR3 AA sequences and cancer antigens may improve patient survival outcomes.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2023)

添加到收藏夹

Article Oncology

BRF2 is mediated by microRNA-409-3p and promotes invasion and metastasis of HCC through the Wnt/β-catenin pathway

Jian-Hua Chang et al.

Summary: In this study, BRF2 was identified and validated as an oncogene in hepatocellular carcinoma (HCC), shedding light on the pathogenesis and therapeutic possibilities for HCC. BRF2 expression was upregulated in HCC, while its depletion inhibited HCC metastasis and invasion. Additionally, miR-409-3p was identified as a regulator of BRF2, and the Wnt/beta-catenin signaling pathway may play a role in early HCC development.

CANCER CELL INTERNATIONAL (2023)

添加到收藏夹

Article Oncology

Cancer statistics, 2022

Rebecca L. Siegel et al.

Summary: Each year, the American Cancer Society compiles data on cancer occurrence and outcomes in the United States. The latest data shows that breast and prostate cancer progress has stagnated, while lung cancer has shown improvements in survival rates. Lung cancer incidence for advanced disease has declined while localized-stage rates have increased, resulting in higher survival rates. Mortality patterns align with incidence trends, with lung cancer deaths declining rapidly, breast cancer deaths slowing, and prostate cancer deaths stabilizing.

CA-A CANCER JOURNAL FOR CLINICIANS (2022)

添加到收藏夹

Article Oncology

Quantification of T- and B-cell Immune Receptor Distribution Diversity Characterizes Immune Cell Infiltration and Lymphocyte Heterogeneity in Clear Cell Renal Cell Carcinoma

Meghan C. Ferrall-Fairbanks et al.

CANCER RESEARCH (2022)

添加到收藏夹

Article Oncology

The burden of primary liver cancer caused by specific etiologies from 1990 to 2019 at the global, regional, and national levels

Jianqing Yang et al.

Summary: This study presents the burden of liver cancer at the global, regional, and national levels. Liver cancer remains a major public health issue worldwide, with a high number of mortalities and incident cases in 2019. Hepatitis B and Hepatitis C are the main causes of liver cancer mortality. China has the highest burden of liver cancer, both in terms of deaths and disease burden.

CANCER MEDICINE (2022)

添加到收藏夹

Article Neurosciences

Immunogenomics Parameters for Patient Stratification in Alzheimer's Disease

Taha Huda et al.

Summary: This study aimed to understand the chemical features of adaptive immune receptors in Alzheimer's disease (AD). Through analyzing T-cell receptor alpha (TRA) complementarity determining region-3 (CDR3), the researchers found associations between certain TRA CDR3 features and the severity of AD. The study also suggested that evaluating the adaptive immune response to tau could potentially serve as a basis for AD risk stratification.

JOURNAL OF ALZHEIMERS DISEASE (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Chemical complementarity between tumor resident, T-cell receptor CDR3s and MAGEA3/6 correlates with increased melanoma survival: Potential relevance to MAGE vaccine auto-reactivity

Rachel A. Eakins et al.

Summary: This study used a chemical complementarity scoring algorithm and a web tool to investigate the electrostatic complementarity between cancer testis antigens and T-cell receptors in melanoma specimens. The results showed that stronger electrostatic complementarity was associated with higher overall survival and increased expression of cytotoxicity-related genes.

MOLECULAR IMMUNOLOGY (2022)

添加到收藏夹

Review Oncology

Adoptive Cell Therapy in Hepatocellular Carcinoma: Biological Rationale and First Results in Early Phase Clinical Trials

Philippe Rochigneux et al.

Summary: The mortality of hepatocellular carcinoma (HCC) is rapidly increasing worldwide, and immunotherapy involving engineered T cells has shown promising results in clinical trials for combating liver cancer.

CANCERS (2021)

添加到收藏夹

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

添加到收藏夹

Article Biology

Twelve years of SAMtools and BCFtools

Petr Danecek et al.

Summary: SAMtools and BCFtools are widely used tools for processing high-throughput sequencing data, with a history of 12 years of continuous development and improvement. These packages have been utilized in various software projects and genomic pipelines and are freely available on GitHub.

GIGASCIENCE (2021)

添加到收藏夹

Review Gastroenterology & Hepatology

Advances in immunotherapy for hepatocellular carcinoma

Bruno Sangro et al.

Summary: Immunotherapeutic interventions have shown effectiveness in the treatment of hepatocellular carcinoma. Checkpoint inhibitors have demonstrated strong anti-tumor activity, but other immune strategies have not yet shown consistent clinical activity. Advancing treatment to earlier stages, discovering predictive biomarkers, and exploring effective combinatorial approaches are key challenges in HCC immunotherapy.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)

添加到收藏夹

Article Genetics & Heredity

A comparison of immune receptor recombination databases sourced from tumour exome or RNAseq files: Verifications of immunological distinctions between primary and metastatic melanoma

Dhruv N. Patel et al.

Summary: It has been found that RNAseq and exome files prepared from tissue can be utilized for analyzing adaptive immune receptor recombination, adding value to datasets originally intended for gene expression or mutation studies. The two sets of IR recombination reads largely agree on several parameters, but using CDR3 chemical features for survival distinctions shows inconsistency. Recovery of TRB recombination reads from metastatic melanoma is associated with a better outcome, while the recovery of IR recombination reads from primary melanoma indicates a worse outcome.

INTERNATIONAL JOURNAL OF IMMUNOGENETICS (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

High-throughput, sliding-window algorithm for assessing chemical complementarity between immune receptor CDR3 domains and cancer mutant peptides: TRG-PIK3CA interactions and breast cancer

Boris I. Chobrutskiy et al.

Summary: Physicochemical assessments of adaptive immune receptor recombinations have led to correlations with subdivisions of diseases. In cancer settings, assessments of the immune receptor CDR3 domain have been used to establish chemical complementarity matches to mutant amino acids, correlating with survival and gene expression distinctions. This approach has been expanded to include a more comprehensive representation of T-cell receptor CDR3 interactions with mutant amino acids, showing significant patient subdivisions and enabling more efficient development of patient immunology-related prognostic tools and therapies.

MOLECULAR IMMUNOLOGY (2021)

添加到收藏夹

Editorial Material Immunology

Electrostatic complementarity of B-cell receptor CDR3s and TP53-mutant amino acids in breast cancer is associated with increased disease-free survival rates

Juan F. Arturo et al.

CELLULAR & MOLECULAR IMMUNOLOGY (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Chemical complementarity between immune receptor CDR3s and IDH1 mutants correlates with increased survival for lower grade glioma

Boris Chobrutskiy et al.

ONCOGENE (2020)

添加到收藏夹

Article Immunology

A scoring system for the electrostatic complementarities of T-cell receptors and cancer-mutant amino acids: multi-cancer analyses of associated survival rates

Boris I. Chobrutskiy et al.

IMMUNOLOGY (2020)

添加到收藏夹

Article Oncology

Silencing of BRF2 inhibits the growth and metastasis of lung cancer cells

Yuan Bian et al.

MOLECULAR MEDICINE REPORTS (2020)

添加到收藏夹

Article Oncology

T-cell receptor-α CDR3 domain chemical features correlate with survival rates in bladder cancer

Boris I. Chobrutskiy et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2019)

添加到收藏夹

Article Immunology

The Immune Landscape of Cancer

Vesteinn Thorsson et al.

IMMUNITY (2018)

添加到收藏夹

Article Oncology

Recovery of T-cell receptor V(D)J recombination reads from lower grade glioma exome files correlates with reduced survival and advanced cancer grade

Boris I. Chobrutskiy et al.

JOURNAL OF NEURO-ONCOLOGY (2018)

添加到收藏夹

Review Gastroenterology & Hepatology

Hepatitis C Virus and Hepatocellular Carcinoma: A Narrative Review

Page Axley et al.

JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY (2018)

添加到收藏夹

Article Oncology

Assessing microenvironment immunogenicity using tumor specimen exomes: Co-detection of TcR-α/β V(D)J recombinations correlates with PD-1 expression

Yaping N. Tu et al.

INTERNATIONAL JOURNAL OF CANCER (2017)

添加到收藏夹

Letter Genetics & Heredity

Ultrasensitive detection of TCR hypervariable-region sequences in solid-tissue RNA-seq data

Bo Li et al.

NATURE GENETICS (2017)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Identification of immunoglobulin V(D)J recombinations in solid tumor specimen exome files: Evidence for high level B-cell infiltrates in breast cancer

Wei Lue Tong et al.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)

添加到收藏夹

Article Immunology

Anti-GPEC3-CAR T Cells Suppress the Growth of Tumor Cells in Patient-Derived Xenogratfts of Hepatocelluar Carcinoma

Zhiwu Jiang et al.

FRONTIERS IN IMMUNOLOGY (2017)

添加到收藏夹

Article Oncology

TCR gene-modified T cells can efficiently treat established hepatitis C-associated hepatocellular carcinoma tumors

Timothy T. Spear et al.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2016)

添加到收藏夹

Article Oncology

Detection of Productively Rearranged TcR-α V-J Sequences in TCGA Exome Files: Implications for Tumor Immunoscoring and Recovery of Antitumor T-cells

Thomas R. Gill et al.

CANCER INFORMATICS (2016)

添加到收藏夹

Article Gastroenterology & Hepatology

World-wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma

Catherine de Martel et al.

HEPATOLOGY (2015)

添加到收藏夹

Article Genetics & Heredity

Profiling tissue-resident T cell repertoires by RNA sequencing

Scott D. Brown et al.

GENOME MEDICINE (2015)

添加到收藏夹

Review Gastroenterology & Hepatology

Hepatitis C virus-induced hepatocellular carcinoma

Nicolas Goossens et al.

CLINICAL AND MOLECULAR HEPATOLOGY (2015)

添加到收藏夹

Article Oncology

Development of T Cells Redirected to Glypican-3 for the Treatment of Hepatocellular Carcinoma

Huiping Gao et al.

CLINICAL CANCER RESEARCH (2014)

添加到收藏夹

Article Genetics & Heredity

Functionally distinct gene classes as bigger or smaller transcription factor traps: A possible stochastic component to sequential gene expression programs in cancer

James A. Mauro et al.

GENE (2014)

添加到收藏夹

Article Biochemistry & Molecular Biology

Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal

Jianjiong Gao et al.

SCIENCE SIGNALING (2013)

添加到收藏夹

Article Biochemical Research Methods

Predicting Disease Risk Using Bootstrap Ranking and Classification Algorithms

Ohad Manor et al.

PLOS COMPUTATIONAL BIOLOGY (2013)

添加到收藏夹

Editorial Material Oncology

The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data

Ethan Cerami et al.

CANCER DISCOVERY (2012)

添加到收藏夹

Review Biochemistry & Molecular Biology

RNA polymerase III transcription in cancer: the BRF2 connection

Stephanie Cabarcas et al.

MOLECULAR CANCER (2011)

添加到收藏夹

Article Medicine, General & Internal

Integrative Genomic Analyses Identify BRF2 as a Novel Lineage-Specific Oncogene in Lung Squamous Cell Carcinoma

William W. Lockwood et al.

PLOS MEDICINE (2010)

添加到收藏夹

Article Biochemistry & Molecular Biology

Differential expression of the TFIIIB subunits Brf1 and Brf2 in cancer cells

Stephanie Cabarcas et al.

BMC MOLECULAR BIOLOGY (2008)

添加到收藏夹

Article Oncology

Genomic analysis of the 8p11-12 amplicon in familial breast cancer

Lorenzo Melchor et al.

INTERNATIONAL JOURNAL OF CANCER (2007)

添加到收藏夹

Review Immunology

Cellular and molecular mechanisms of liver tolerance

Ian N. Crispe et al.

IMMUNOLOGICAL REVIEWS (2006)

添加到收藏夹

Article Biochemistry & Molecular Biology

A 1Mb minimal amplicon at 8p11-12 in breast cancer identifies new candidate oncogenes

MJ Garcia et al.

ONCOGENE (2005)

添加到收藏夹

Review Cell Biology

RNA polymerases I and III, growth control and cancer

RJ White

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)

添加到收藏夹

Review Biochemistry & Molecular Biology

RNA polymerase III transcription and cancer

RJ White

ONCOGENE (2004)

添加到收藏夹

Review Cell Biology

Recruitment of RNA polymerase III to its target promoters

L Schramm et al.

GENES & DEVELOPMENT (2002)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.